Search clinical trials for: CD 2027

Total 483 results

Novindiet Clinic
Tehran University of Medical Sciences; University of Nottingham

Completed

Effects of Internet-based Diet Plus Online Dietary Coach Compared With in Person Clinic Visit Approach on Weight Loss

Obesity | Overweight

Iran, Islamic Republic of
Mayo Clinic

Withdrawn

New Methods to Diagnose Constrictive Pericarditis

Constrictive Pericarditis

United States
Duke University
National Cancer Institute (NCI)

Completed

Computer Program in Improving Communication Between Doctors and Patients With Stage IV Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Novo Nordisk A/S

Completed

First Research Study of the Possible New Medicine NNC0113-2023 in Healthy Men.

Diabetes Mellitus, Type 2

United States
University of Missouri-Columbia
National Institute on Minority Health and Health Disparities (NIMHD)

Recruiting

Effects of a Personalized Diet on Cardiometabolic, Microbiome and Metabolomics Profiles in Minority Young Adults

Diet Intervention

United States
Mayo Clinic

Withdrawn

Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support (CD-NP/LVAD)

Heart Failure | Left Ventricular Assist Device | Natriuretic Peptide
IRCCS San Raffaele

Not yet recruiting

Unveiling the Microbial Impact on Intestinal Fibrosis

Crohn Disease

Italy
Medtronic Spinal and Biologics

Completed

INFUSE® Bone Graft and MASTERGRAFT® Granules With CD HORIZON® for Posterolateral Lumbar Fusion in Patients With Degenerative Disc Disease - Pilot Study

Degenerative Disc Disease
Lancaster General Hospital

Withdrawn

Study to Determine the Safety and Feasibility of Utilizing the CD Leycom Pressure/Conductance Catheter to Determine Optimal LV Pacing Site

Heart Failure

United States
Eisai Inc.

Completed

Study to Assess the Safety, Tolerability, Pharmacokinetics of E2027 in Healthy Adult and Elderly Subjects, and the Pharmacodynamics in Healthy Adult Subjects

Healthy Participants

United States
Boston University Charles River Campus
Massachusetts Institute of Technology

Not yet recruiting

Neural Mechanisms of Family-Focused Treatment for Youth Depression

Childhood Depression

United States
University of Cologne
Medtronic

Unknown

"Efficacy of Hybrid Systems ("Topping Off") Versus Rigid Spinal Fusion in Lumbar Fusion Surgery: A Dual-center, Prospective, Randomized Pilot Study ("CD Horizon BalanC")" (BalanC)

Spine Surgery
Icahn School of Medicine at Mount Sinai
National Institute of Mental Health (NIMH); William Marsh Rice University

Recruiting

Cognitive Reappraisal Training for Borderline Personality (BPD)

Borderline Personality Disorder

United States
Eisai Inc.

Completed

A Study of E2027 in Participants With Dementia With Lewy Bodies (DLB) or Parkinson's Disease Dementia (PDD) With or Without Amyloid Copathology

Parkinson Disease | Lewy Body Disease

United States, Canada
Eisai Inc.

Completed

A Study to Determine the Metabolism and Elimination of [14C]E2027 in Healthy Male Participants

Dementias With Lewy Bodies

United States
3H (Suzhou) Pharmaceuticals Co., Ltd.

Not yet recruiting

A Study of 3HP-2827 in Treatment of Unresectable or Metastatic Solid Tumors With FGFR2 Alterations

Solid Tumors With FGFR2 Alterations, Adult

China
Shanghai Jiao Tong University School of Medicine

Recruiting

Autologous Transplantation of Expanded Pancreatic Islet Cells (YD01-2022) in Patients

Diabetes After Total Pancreatectomy

China
Tongji Hospital
Shanghai Zhongshan Hospital; Peking University Third Hospital; Huashan Hospital; First Affiliated Hospital Xi'an Jiaotong University and other collaborators

Completed

Quality Control and Evaluation in Standard COPD Management

COPD

China
Georgetown University
U.S. Army Medical Research and Development Command

Completed

Treatment Decision Making in Early-Stage Prostate Cancer

Localized Prostate Cancer

United States
Anterogen Co., Ltd.

Recruiting

A Follow-up Study to Evaluate the Safety of ALLO-ASC-CD in ALLO-ASC-CD-101 Clinical Trial

Crohn Disease

Korea, Republic of
NeuroDerm Ltd.

Active, not recruiting

Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations (BouNDless)

Parkinson's Disease

United States, Israel, Spain, France, Russian Federation, Austria, Italy, Belgium, Czechia, Hungary, Netherlands, Poland, Portugal, Slovakia, Ukraine, United Kingdom
University Hospital, Basel, Switzerland

Completed

Resilience and Quality of Life in Patients With Gynaecological Carcinomas and Chronic Gynaecological Diseases

Gynecologic Cancer | Gynecologic Disease

Switzerland
Ain Shams University

Unknown

Effect of Expression of CD74 and VEGF on Outcome of Treatment in Patients With Malignant Pleural Mesothelioma

Malignant Pleural Mesothelioma
Intec Pharma Ltd.

Withdrawn

Gastric Retentive Carbidopa/ Levodopa in Parkinson's Patients; a One Year, Open Label, Safety Extension Study

Parkinson's Disease

Israel
Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Not yet recruiting

Phase I Study of SHR-2022 Injection in the Treatment of Patients With Advanced Malignant Tumors

Advanced Malignant Cancer
Eisai Inc.

Completed

Study To Evaluate the Efficacy, Safety and Tolerability of E2027 (Hereinafter Referred to as Irsenontrine) in Participants With Dementia With Lewy Bodies

Dementia With Lewy Bodies

United States, Spain, France, Germany, Italy, Japan, United Kingdom
Promentis Pharmaceuticals, Inc.

Completed

Randomized, Double-Blind, Placebo-Controlled, MAD Study to Assess the Safety, Tolerability, and Pharmacokinetics of SXC 2023

Healthy Volunteers

United States
Conatus Pharmaceuticals Inc.
FGK Clinical Research GmbH

Completed

Study of CTS-1027 in Hepatitis C Patients

Chronic Hepatitis C Virus Infection

United States
Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Not yet recruiting

PK/PD Study of SHR-2017 Injection in Patients With Bone Metastases

Patients With Bone Metastases

China
Shanghai Jiao Tong University School of Medicine

Recruiting

Allogeneic Transplantation of Expanded Pancreatic Islet Cells

Brittle Type 1 Diabetes

China
VGX Pharmaceuticals, LLC
GeneOne Life Science, Inc.

Completed

Multiple-Dose Study of VGX-1027 in Healthy Subjects

Healthy

United States
Bispebjerg Hospital
University of Copenhagen; University of Aarhus; The Danish Dairy Research Foundation... and other collaborators

Active, not recruiting

Cut Down on Carbohydrate in the Dietary Therapy of Type 2 Diabetes - The Meal Box Study (CutDM-MealBox)

Diabetes Mellitus Type 2 | Overweight and Obesity

Denmark
Rutgers, The State University of New Jersey
National Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center; Columbia... and other collaborators

Completed

Facilitating Parent Adaptation to Pediatric Transplant: The P-SCIP Trial (P-SCIP)

Childhood Cancers

United States
John A. Schirger
National Institutes of Health (NIH)

Withdrawn

Effects of Chimeric Natriuretic Peptide Versus Placebo in Stable Heart Failure and Moderate Renal Dysfunction

Heart Failure | Renal Insufficiency
Pilar Jimenez Quevedo
Fundación Mutua Madrileña

Completed

Safety and Efficacy of Autologous Endothelial Progenitor Cell CD 133 for Therapeutic Angiogenesis (PROGENITOR)

Coronary Artery Disease | Refractory Angina

Spain
BackBeat Medical Inc
CD Leycom

Recruiting

Preload and Autonomic Responses With Cardiac Neuromodulation Therapy (CNT) (CS-06) (CS-06)

Bradycardia | Hypertension, Systolic

Czechia
Bispebjerg Hospital
University of Copenhagen; University of Aarhus; The Danish Dairy Research Foundation... and other collaborators

Completed

Cut Down on Carbohydrate Usage in the Diet of Type 2 Diabetes. The Hypo-energetic Study (CutDM-Hypo)

Diabetes Mellitus, Type 2 | Overweight and Obesity

Denmark
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Completed

CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation

Multiple Myeloma | Hodgkin's Lymphoma | AML | Hematologic Malignancy | NHL | CML | ALL

United States
Chong Kun Dang Pharmaceutical

Recruiting

A Study to Evaluate the PK, PD and Safety of CKD-382 in Healthy Subjects

GERD

Korea, Republic of
Novo Nordisk A/S

Completed

Investigation of the Pharmacokinetics of NNC172-2021, at Two Different Dose Levels, in Healthy Japanese Subjects

Healthy | Congenital Bleeding Disorder | Haemophilia A | Haemophilia B

United Kingdom
Impax Laboratories, LLC

Completed

An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects With Parkinson's Disease

Parkinson's Disease

United States, Canada, Estonia, Latvia, Lithuania, Romania, Ukraine, Germany, Poland, Spain
Cyclo Therapeutics, Inc.

Active, not recruiting

Open-Label Study of Long-Term Safety and Efficacy of Intravenous Trappsol Cyclo (HPβCD) in Niemann-Pick Disease Type C

Niemann-Pick Disease, Type C1

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Completed

Educational CD-ROM Compared With Standard Informed Consent for Patients With Colorectal Cancer or a Family History of Colorectal Cancer

Colorectal Cancer | Hereditary Non-polyposis Colon Cancer

United States
Gangnam Severance Hospital
Daewoong Pharmaceutical Co. LTD.

Completed

Safety and Effectiveness Study of Allogeneic Umbilical Cord Blood-derived Mesenchymal Stem Cell in Patients With RDEB

Recessive Dystrophic Epidermolysis Bullosa

Korea, Republic of
University of Glasgow

Completed

The Impact of "Crohn's Disease-TReatment-with-EATing" Diet and Exclusive Enteral Nutrition on Healthy Gut Bacteria

Crohn's Disease | Dietary Modification

United Kingdom
Education Development Center, Inc.

Unknown

Addressing Proven Factors in HIV Prevention for Latino Youth

HIV | Sexually Transmitted Infections
Evofem Inc.
Neothetics, Inc

Terminated

Extension Study to Evaluate the Post-Treatment Safety and Duration of Clinical Effect of LIPO-202

Central Abdominal Bulging
3H (Suzhou) Pharmaceuticals Co., Ltd.

Not yet recruiting

A First-in-human Study of 3HP-2827 in Patients With Unresectable or Metastatic Solid Tumors With FGFR2 Alterations

Solid Tumors With FGFR2 Alterations, Adult

United States
Novo Nordisk A/S

Terminated

A Multi-centre, Open Labelled, Multiple Dosing Trial Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC 0172-2021 Administered Subcutaneously to Healthy Male Subjects and Haemophilia Subjects (explorer™2)

Healthy | Congenital Bleeding Disorder | Haemophilia A

Austria, Spain, United Kingdom, France, Germany
VGX Pharmaceuticals, LLC
GeneOne Life Science, Inc.

Completed

Phase I Safety and Pharmacokinetic Study of VGX-1027 in Healthy Subjects

Healthy

United States

Search clinical trials for: CD 2027

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Serbia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations